Back

Early epidemiological signatures of novel SARS-CoV-2 variants: establishment of B.1.617.2 in England

Challen, R.; Dyson, L.; Overton, C.; Guzman-Rincon, L.; Hill, E.; Stage, H.; Brooks-Pollock, E.; Pellis, L.; Scarabel, F.; Pascall, D. J.; Blomquist, P.; Tildesley, M. J.; Williamson, D.; Siegert, S.; Xiong, X.; Youngman, B.; Consortium, J.; Read, J. M.; Gog, J. R.; Keeling, M. J.; Danon, L.

2021-06-07 epidemiology
10.1101/2021.06.05.21258365 medRxiv
Show abstract

The rapid emergence of SARS-CoV-2 mutants with new phenotypic properties is a critical challenge to the control of the ongoing pandemic. B.1.1.7 was monitored in the UK through routine testing and S-gene target failures (SGTF), comprising over 90% of cases by March 2021. Now, the reverse is occurring: SGTF cases are being replaced by an S-gene positive variant, which we associate with B.1.617.2. Evidence from the characteristics of S-gene positive cases demonstrates that, following importation, B.1.617.2 is transmitted locally, growing at a rate higher than B.1.1.7 and a doubling time between 5-14 days. S-gene positive cases should be prioritised for sequencing and aggressive control in any countries in which this variant is newly detected. One-Sentence SummaryThe B.1.617.2 variant of SARS-CoV-2 is replacing B.1.1.7 and emerging as the dominant variant in England, evidenced by sustained local transmission.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.